Responding to FDA Form 483 Observations at the Conclusion of a Drug CGMP Inspection: Draft Guidance for Industry; Availability

5 organizations filed 5 public comments on Responding to FDA Form 483 Observations at the Conclusion of a Drug CGMP Inspection: Draft Guidance for Industry; Availability, at the Food and Drug Administration. The comment window closed 81d ago.

Commenters (5)

• American Pharmacists Association (APhA)trade assoc.

  1 filing · confidence 97%
• Animal Health Institutetrade assoc.

  1 filing · confidence 97%
• Association for Accessible Medicinestrade assoc.

  1 filing · confidence 97%
• Consumer Healthcare Products Associationtrade assoc.

  1 filing · confidence 97%
• Parenteral Drug Associationtrade assoc.

  1 filing · confidence 97%